corporate interests


US using trade deals to shield tech giants from foreign regulations
The US administration's push is the latest salvo in a global fight over who sets the rules for the Internet.
City of London representatives head to US to promote post-Brexit finance ties
Representatives from the City of London are to travel to the US in a bid to boost transatlantic ties for the finance sector post-Brexit.
Ricardo Salles to meet with European chemical and car giants
Leaked agenda shows Brazil’s environment minister will meet with BASF, Bayer, VW and British fossil fuel and mining interests.
What the AfCFTA means for the energy sector
Major new opportunities for cross-border energy collaboration arise from the signature of the African Continental Free Trade Area (AfCFTA) agreement.
US businesses urge Thailand to join CPTPP
The US-Asean Business Council is is calling for the Thai government to join the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP).
Corporations have 'hijacked justice'
Regional Comprehensive Economic Partnership trade deal would undermine environmental protections in Asia.
ILO, Bayer congratulate Việt Nam, EU on signing free trade deal
Private sector companies like Bayer are looking forward to further institutional and policy reforms after the EVFTA ratification which can consequently create favourable conditions to promote the business and investment environment.
Analysis: EU-Vietnam FTA opens up petchem trade options
A landmark free-trade agreement (FTA) between Vietnam and the EU will open up options for new petrochemical trade flows, but may not lead to a quick shift away from Hanoi's main export markets in China and southeast Asia.
Connecting the dots: Insane trade and climate chaos
The connection between global trade and the climate crisis is clear. Much of global trade is unnecessary and wasteful - and yet, somehow, it continues to be profitable.
Tobacco as an ‘offensive interest’ in trade talks? The role of rules of origin
Beyond ISDS, another potential trade policy issue lurks in the background and which has not yet captured the attention of the health policy community: rules of origin in trade agreements.